Will tomorrow's medicines work for everyone? (Q35929119)

11 August 2017

1 reference

title

Will tomorrow's medicines work for everyone? (English)

1 reference

11 August 2017

Sarah K Tate

1

1 reference

11 August 2017

David B Goldstein

series ordinal

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

36

1 reference

11 August 2017

issue

11 Suppl

1 reference

11 August 2017

page(s)

S34-42

1 reference

Social inequality, ethnicity and cardiovascular disease

11 August 2017

cites work

1 reference

Blunted blood pressure response to central sympathoinhibition in normotensive blacks: increased importance of nonsympathetic factors in blood pressure maintenance in blacks

21 January 2018

1 reference

Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group

21 January 2018

1 reference

Ischemic stroke outcome: racial differences in the trial of danaparoid in acute stroke (TOAST).

21 January 2018

1 reference

A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients

21 January 2018

1 reference

Race, quality of care, and antipsychotic prescribing practices in psychiatric emergency services

21 January 2018

1 reference

Racial differences in treatment of psychiatric inpatients

21 January 2018

1 reference

A vision for the future of genomics research

21 January 2018

1 reference

7 January 2021

Pharmacogenetics goes genomic

1 reference

7 January 2021

Characterization of a common susceptibility locus for asthma-related traits

1 reference

7 January 2021

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

1 reference

7 January 2021

Pharmacogenetics and disease genetics of complex diseases

1 reference

7 January 2021

A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia.

1 reference

7 January 2021

1 reference

7 January 2021

The importance of race and ethnic background in biomedical research and clinical practice

1 reference

7 January 2021

Racial Profiling in Medical Research

1 reference

7 January 2021

A review and assessment of potential sources of ethnic differences in drug responsiveness

1 reference

7 January 2021

Recommendations for the management of special populations: racial and ethnic populations

1 reference

7 January 2021

Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases

1 reference

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

7 January 2021

Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group

1 reference

7 January 2021

Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans

1 reference

7 January 2021

Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial.

1 reference

7 January 2021

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

1 reference

7 January 2021

A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade

1 reference

7 January 2021

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol

1 reference

7 January 2021

Molecular basis of ethnic differences in drug disposition and response

1 reference

7 January 2021

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

1 reference

7 January 2021

Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians

1 reference

7 January 2021

Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.

1 reference

7 January 2021

Results of Therapy for Acute Lymphoblastic Leukemia in Black and White Children

1 reference

7 January 2021

The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics

1 reference

7 January 2021

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment

1 reference

7 January 2021

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

1 reference

7 January 2021

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

1 reference

7 January 2021

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

7 January 2021

MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes

1 reference

7 January 2021

Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs

1 reference

7 January 2021

Linkage disequilibrium in the human genome

1 reference

7 January 2021

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

1 reference

7 January 2021

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations

1 reference

7 January 2021

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

1 reference

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

7 January 2021

Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease

1 reference

7 January 2021

Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes

1 reference

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

7 January 2021

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

7 January 2021

Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status

1 reference

7 January 2021

Integrating ethics and science in the International HapMap Project

1 reference

7 January 2021

Genome-based pharmacogenetics and the pharmaceutical industry

1 reference

7 January 2021

Pharmacogenetics and the future of medical practice

1 reference

7 January 2021

Population genetic structure of variable drug response

1 reference

7 January 2021

Genetic structure of human populations

1 reference

7 January 2021

A High-Density Admixture Map for Disease Gene Discovery in African Americans

1 reference

7 January 2021

The case for a US prospective cohort study of genes and environment

1 reference

7 January 2021

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction

1 reference

7 January 2021

Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group

1 reference

7 January 2021

Vasodilation in black Americans: Attenuated nitric oxide-mediated responses*

1 reference

7 January 2021

Ethnicity affects vasodilation, but not endothelial tissue plasminogen activator release, in response to bradykinin

1 reference

7 January 2021

A comparison of verapamil and propranolol for the initial treatment of hypertension. Racial differences in response

1 reference

7 January 2021

Gly389Arg polymorphism of β1-adrenergic receptor is associated with the cardiovascular response to metoprolol

1 reference

7 January 2021

Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo

1 reference

7 January 2021

Efficacy of Nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension

1 reference

7 January 2021

United states experience with oxprenolol in hypertension

1 reference

7 January 2021

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

7 January 2021

Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

7 January 2021

Recent clinical trials with omapatrilat: new developments

1 reference

7 January 2021

Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0.

1 reference

7 January 2021

Ethnic background is a determinant of average warfarin dose required to maintain the INR between 3.0 and 4.5.

1 reference

7 January 2021

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

7 January 2021

Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients

1 reference

7 January 2021

Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension

1 reference

7 January 2021

Cellular calcium and sodium regulation, salt‐sensitivity and essential hypertension in African Americans

1 reference

7 January 2021

Reduced β2-receptor mediated vasodilation in African Americans

1 reference

7 January 2021

Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function

1 reference

7 January 2021

Attenuation of isoproterenol-mediated vasodilatation in blacks

1 reference

7 January 2021

Racial differences in beta-adrenoceptor-mediated responsiveness.

1 reference

7 January 2021

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

1 reference

7 January 2021

Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension

1 reference

7 January 2021

Racial and ethnic differences in survival of children with acute lymphoblastic leukemia

1 reference

7 January 2021

Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study

1 reference

7 January 2021

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients.

1 reference

7 January 2021

Insulin resistance and associated compensatory responses in african-american and Hispanic children

1 reference

7 January 2021

Haloperidol and reduced haloperidol plasma levels in Chinese vs. non-Chinese psychiatric patients

1 reference

7 January 2021

Patients with schizophrenia at risk for excessive antipsychotic dosing

1 reference

7 January 2021

Ethnic differences in response to morphine

1 reference

7 January 2021

Ethnicity influences morphine pharmacokinetics and pharmacodynamics

1 reference

7 January 2021

Identifiers

DOI

10.1038/NG1437

1 reference

11 August 2017

1 reference